CD44 Polyclonal Antibody bs-0521R from Bioss Inc.

Product Specs
ItemCD44 Polyclonal Antibody
CompanyBioss Inc.
Price Pricing Info Supplier Page View Company Product Page
Catalog Numberbs-0521R
Molecular Weight85kDa
Brand/TrademarkBioss
ImmunogenKLH conjugated peptide, human CD44
Quantity100ul
IsotypeIgG
ApplicationsWB, ELISA, FCM, IHC-P, IF(IHC-P), IF(ICC)
Conjugate/TagUnconjugated
Antibody TypePrimary Antibody
ReactivityHuman, Mouse, Rat, Rabbit, Others
ClonalityPolyclonal
Format0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol
TargetCD44
HostRabbit
Concentration1ug/ul
NCBI Gene AliasesHCELL, MDU3, CSPG8, MIC4, MC56, HUTCH-I, LHR, MDU2, IN, ECMR-III, Pgp1, CDW44
NCBI Full Gene NameCD44 molecule (Indian blood group)
PurityProtein A purified

Add to Compare List

Bioss Inc.

400 Trade Center, Suite 2990

Woburn, Massachusetts 01801

United States

Phone: 800.501.7654 (Toll free)
Phone: +1.781.569.5821 (International)

Email: info@biossusa.com
orders@biossusa.com
support@biossusa.com
business@biossusa.com

Company Profile

Website: www.biossusa.com

(1) SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating MYH9‐Mediated GSK3β/β‐Catenin SignalingAdvanced ScienceApril 1, 2023Qing Li, Hao Luo, Fu‐Qiang Dai, Ren‐Tao Wang, Xiao‐Qing Fan, Yuan‐Yuan Luo, Meng‐Sheng Deng, Yulun Wang, Tan Long, Wei Guo, et al.E‐cadherin(14472S) were purchased from Cell Signaling Technology (Boston, MA, USA). Antibodies against CD44 (bs‐0521R) and GST (bs‐2122R) were obtained from Bioss (Beijing, China). Animal Experiments Six‐week‐old BALB/c

(2) Angiogenesis and bone regeneration by mesenchymal stem cell transplantation with danshen in a rabbit model of avascular necrotic femoral headExperimental and Therapeutic MedicineMay 8, 2019Yungang Wu, Chunwu Zhang, Jianjing Wu, Yan Han, Chunlei Wuincubated with the anti-rabbit antibodies, CD34 (1:300; cat. no. bs-2042R) and CD44 (1:300; cat. no. bs-0521R) at 4°C overnight. All antibodies were purchased from BIOSS (Beijing, China). Cells were then observed

(3) Expression of MMP-14 and CD44 associated with proliferation of retinoblastoma cellsMedicine Science | International Medical JournalJanuary 1, 2019Hendrian Soebagjo, Evelyn Komaratih, Susy Fatmariyanti, Nurwasis Nurwasis, Aulanniam Aulanniam2019;8(2):354-9 primary Rabbit Monoclonal Antibody Anti-CD44/HCAM/PGP1, Primary Polyclonal Antibody (bs-0521R) Bioss Inc. (1:150), Anti MMP-14 Polyclonal Antibody (NB100-91872) Novus Biological (1:300), and Ki-67

(4) Characteristics and multi‑lineage differentiation of bone marrow mesenchymal stem cells derived from the Tibetan mastiffMolecular medicine reportsAugust 1, 2018Zhang S, Zhao C, Liu S, Wang Y, Zhao Y, Guan W, Zhu Z.incubated with the following antibodies: Anti-CD29 (cat. no. bs-20631R; 1:200); anti-CD44 (cat. no. bs-0521R; 1:200), anti-CD90 (cat. no. bs-0778R; 1:200); anti-CD105 (cat. no. bs-0579R; 1:200); anti-vimentin

(5) The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptorJournal of neuroinflammationMarch 8, 2018Neal ML, Boyle AM, Budge KM, Safadi FF, Richardson JR.15:73 MA). The rabbit polyclonal GPNMB (Cat. #: bs2684r) and rabbit polyclonal CD44 antibody (Cat. #: bs-0521r) was purchased from Bioss (Woburn, MA). 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and all

(6) Bone mesenchymal stem cells co-expressing VEGF and BMP-6 genes to combat avascular necrosis of the femoral headExperimental and therapeutic medicineJanuary 1, 2018Liao H, Zhong Z, Liu Z, Li L, Ling Z, Zou X.1:200, Abcam, Cambridge, UK), CD29 (cat no. bs-20631R; 1:200; Bioss, Beijing, China), CD44 (cat no. bs-0521R; 1:200, Bioss), CD11 (cat no. bs-2508R; 1:200; Bioss), CD45 (cat no. bs-0522R; 1:200; Bioss) and CD34

(7) Effects of neuritin on the differentiation of bone marrow-derived mesenchymal stem cells into neuron-like cellsMolecular Medicine ReportsJuly 14, 2017Jingling Zhu, Pingping Meng, Qian Wang, Haiyan Wang, Jinli Zhang, Yuanyuan Li, Dongzheng Li, Xiaohua Tan, Lei Yang, Jin HuangCD90 (1:100; cat. no. bs-0778R; Bioss), CD34 (1:100; cat. no. bs-0646R; Bioss), CD44 (1:100; cat. no. bs-0521R; Bioss), or CD45 (1:100; cat. no. bs-0522R; Bioss). PBS was utilized as a negative control. Subsequently,

(8) Bone Marrow Mesenchymal Stem-Cell Transplantation Promotes Functional Improvement Associated with CNTF-STAT3 Activation after Hemi-Sectioned Spinal Cord Injury in Tree ShrewsFrontiers in cellular neuroscienceJanuary 1, 2017Xiong LL, Liu F, Lu BT, Zhao WL, Dong XJ, Liu J, Zhang RP, Zhang P, Wang TH.

(9) Differentiation of rat dermal mesenchymal cells and calcification in three-dimensional culturesTissue Engineering and Regenerative MedicineOctober 1, 2016Taiki Suyama, Mitsutoki Hatta, Shozaburo Hata, Hiroyuki Ishikawa, Jun Yamazakianti-dentin matrix protein-1 (DMP-1) (M176; TaKaRa Bio., Otsu, Japan), rabbit polyclonal anti-CD44 (bs-0521R; Bioss, Inc., Woburn, MA, USA), and rabbit polyclonal anti-CD90/Thy-1 (bs-0778R; Bioss Inc.). LY364947

(10) NIBP impacts on the expression of E-cadherin, CD44 and vimentin in colon cancer via the NF-κB pathwayMolecular medicine reportsJune 1, 2016Xu CY, Qin MB, Tan L, Liu SQ, Huang JA.IL, USA), and rabbit polyclonal anti‑CD44 (1:500) was obtained from BIOSS (Beijing, China; cat. no. bs‑0521R) and ProteinTech Group, Inc. (cat. no. 15675 1‑AP). Statistical analysis. Each experiment was performed

(11) Subchondral bone changes and chondrogenic capacity of progenitor cells from subchondral bone in the collagenase-induced temporomandibular joints osteoarthritis rabbit modelInternational journal of clinical and experimental pathologyJanuary 1, 2015Guomin Wu, Songsong Zhu, Xiumei Sun, Jing Hu

(12) Characterization of sphere‑forming cells with stem‑like properties from the gastric cancer cell lines MKN45 and SGC7901Molecular medicine reportsDecember 1, 2014Wang X, Zou F, Deng H, Fu Z, Li Y, Wu L, Wang Z, Liu L.